Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece
Gourzoulidis, George, Tzanetakos, Charalampos, Ioannidis, Ioannis, Tsapas, Apostolos, Kourlaba, Georgia, Papageorgiou, Giannis, Maniadakis, NikosLanguage:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-018-0620-x
Date:
January, 2018
File:
PDF, 611 KB
english, 2018